The thesis
PanicFade v4 bets that negative headline shocks get overreacted to and revert toward fundamentals. It buys large caps hit by sentiment below -0.4 while they are already oversold — RSI14 under 35 and trading below their 20-day moving average — and sizes into the panic. Exits are equally mechanical: it takes profit on reversion (RSI14 back above 50, or price reclaiming the SMA20) and hard-stops on fresh lows under continued negativity, treating that as a genuine fundamental break rather than noise.
The design is disciplined in the places that usually trip contrarian strategies up: live-quote-only cash accounting, sanity-banded stops, and data-verified rotation across a 24-name blue-chip universe (AAPL, MSFT, NVDA, JPM, V, JNJ, XOM and peers). The academic grounding is contemporary — sentiment-feedback and negative-media overreaction literature from 2025 — rather than a curve-fit to one regime.
Validation holds up
This is where PanicFade v4 earns its keep. Across four walk-forward folds spanning September 2021 to August 2026, every fold was positive (+1.6%, +3.9%, +10.1%, +21.7%). Out-of-sample return came in at 21.7% with an OOS Sharpe of 2.44. Most importantly, the deflated statistics — which penalise for the 27 trials run during search — survive: a Probabilistic Sharpe Ratio of 0.985 and a Deflated Sharpe Ratio of 0.56. A positive DSR after 27 trials is a meaningful signal that the edge is not just multiple-testing luck.
The full backtest returns 37.93% (final equity $13,793 from $10k) over 1,233 days, a 62.9% win rate across 530 trades, and a contained 9.3% max drawdown.
The risks
Be balanced about it. The headline 37.93% flatters a 6.79% CAGR — respectable, not spectacular, and the full-sample Sharpe of 0.96 sits just under one. Turnover is extreme at 5,807%, so the strategy lives or dies on execution quality and cost assumptions; the backtest models only flat $530 in fees and zero FX. Fold 1, covering the 2022 bear, eked out just 1.6% at a 0.19 Sharpe — the edge thins badly when panic is justified and reversion never comes.
Live: nothing is happening
The most honest observation is the quietest. Every scheduled run from 18 to 24 August executed zero trades, rejected zero, and left the paper portfolio pinned at exactly $10,000. No entry conditions have been met for a week. That is arguably the strategy behaving correctly — it only acts on genuine oversold-panic setups, and a calm, grinding-higher tape offers none. But it also means the impressive validation numbers are, for now, entirely theoretical in the live account.
Verdict
PanicFade v4 is one of the better-validated strategies on the platform: positive across every fold, deflated-Sharpe-positive, and mechanically disciplined. The open questions are practical — whether that 5,800% turnover survives real friction, and whether its selective signal fires often enough to matter. Worth watching closely the next time the market actually panics.